TITLE

The Effect of AIDS Clinical Trials Group Protocol 5164 on the Time From Pneumocystis jirovecii Pneumonia Diagnosis to Antiretroviral Initiation in Routine Clinical Practice: A Case Study of Diffusion, Dissemination, and Implementation

AUTHOR(S)
Geng, Elvin H.; Kahn, James S.; Chang, Olivia C.; Hare, C. Bradley; Christopoulos, Katerina A.; Jones, Diane; Petersen, Maya L.; Deeks, Steven G.; Havlir, Diane V.; Gandhi, Monica
PUB. DATE
November 2011
SOURCE
Clinical Infectious Diseases;11/15/2011, Vol. 53 Issue 10, p1008
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Diffusion, dissemination, and implementation of scientific evidence into routine clinical practice is not well understood. The Adult AIDS Clinical Trials Group (ACTG) Protocol 5164 showed that early antiretroviral therapy (ART; ie, within 14 days) after diagnosis of an opportunistic infection improved clinical outcomes, compared with later initiation. Subsequently, the San Francisco General Hospital (SFGH) HIV/AIDS Service performed the SFGH 5164 Initiative to disseminate and implement the findings of ACTG 5164. Methods. We evaluated patients who received a diagnosis of Pneumocystis jirovecii pneumonia (PCP) from 1 January 2001 through 30 March 2011. Survival analyses were used to assess changes in the time to initiation of ART after PCP, and logistic regression was used to evaluate changes in the odds of early ART (ie, within 14 days) because of ACTG 5164 and SFGH 5164 Initiative. Results. Among 162 patients, the adjusted hazard of ART initiation increased by 3.05 (95% confidence interval [CI], 1.86-5.02) after ACTG 5164 and by 4.89 (95% CI, 2.76-8.67) after the SFGH Initiative, compared with before ACTG 5164. When compared with before ACTG 5164, the proportion of patients who received ART within the 14 days after PCP diagnosis increased from 7.4% to 50.0% (P <.001) after ACTG 5164 and from 50.0% to 83.0% (P = .02) after the SFGH 5164 Initiative. Conclusions. Diffusion of findings from of a randomized trial changed practice at an academic medical center, but dissemination and implementation efforts were required to establish early ART at acceptable levels. Early ART initiation can be achieved in real-world patient populations.
ACCESSION #
74614770

 

Related Articles

  • Pneumocystis carinii pneumonia.  // Modern Medicine;Aug95, Vol. 63 Issue 8, p26 

    Reports on the US Food and Drug Administration's approval on the marketing of a suspension form of atovaquone in the treatment of pneumocystis carinii pneumonia. Advantages and convenience; Dosage.

  • Pneumocystis carinii pneumonia prophylaxis reduces mortality, costs.  // Formulary;Sep95, Vol. 30 Issue 9, p544 

    Presents an abstract of the article `The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia,' by J.E. Gallant, S.M. McAvinue, R.D. Moore et al, which appeared in the 1995 issue of `Chest' periodical.

  • Current management practices in the treatment of Pneumocystis carinii pneumonia (PCP). Blanchet, Kevin D. // AIDS Patient Care & STDs;Apr96, Vol. 10 Issue 2, p116 

    Presents a dialogue on current management practices in the treatment of Pneumocystis carinii pneumonia (PCP). Prophylaxis and compliance; Treatment of mild PCP; Patient management issues.

  • Predictores de mortalidad en abdomen abierto por trauma grave. Experiencia del Hospital Central Militar. García-Núñez, Luis Manuel; Macías-Millán, Jorge Antonio; Delgado-Arámburo, José Lauro Gilberto; Cabello-Pasini, Ruy; Núñez-Cantú, Olliver; Soto-Ortega, Enrique; Rivera-Cruz, José María // Revista de Sanidad Militar;jul/aug2011, Vol. 65 Issue 4, p148 

    Background. There are not available national series focusing on factors related to mortality in trauma patients undergoing open-abdomen technique; referring international series focus on different objectives, turning them not well-known. Material and methods. Comparative and retrospective study...

  • Pulse Oximetry and P. carinii Pneumonia.  // American Family Physician;10/1/1993, Vol. 48 Issue 5, p866 

    Reports on the evaluation of the effectiveness of exercise oximetry testing in screening for Pneumocystis carinii pneumonia. Study by Chouaid and colleagues, published in the American Review of Respiratory Disease, June 1993 issue; Drawbacks of other tests; Study on patients infected with HIV;...

  • PCP PREVENTION ALERT. Delaney, Martin // Advocate;11/19/91, Issue 590, p37 

    Reports on the medical alert received by physicians from the U.S. National Institutes of Health concerning the prevention of second bouts of Pneumocystis carinii pneumonia. Call for monthly treatments with aerosol pentamidine; Superiority of the oral use of two common antibiotics.

  • Comparative Value of Four Measures of Retention in Expert Care in Predicting Clinical Outcomes and Health Care Utilization in HIV Patients. Reveles, Kelly R.; Juday, Timothy R.; Labreche, Matthew J.; Mortensen, Eric M.; Koeller, Jim M.; Seekins, Daniel; Oramasionwu, Christine U.; Bollinger, Mary; Copeland, Laurel A.; Jones, Xavier; Frei, Christopher R. // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    This study compared the ability of four measures of patient retention in HIV expert care to predict clinical outcomes. This retrospective study examined Veterans Health Administration (VHA) beneficiaries with HIV (ICD-9-CM codes 042 or V08) receiving expert care (defined as HIV-1 RNA viral load...

  • Long- Term Outcomes of Drug- Eluting Stent Therapy for In- Stent Restenosis Versus De Novo Lesions. GAO, ZHAN; XU, BO; YANG, YUE‐JIN; YUAN, JIN‐QING; CHEN, JUE; CHEN, JI‐LIN; QIAO, SHU‐BIN; WU, YONG‐JIAN; YAN, HONG‐BIN; GAO, RUN‐LIN // Journal of Interventional Cardiology;Dec2013, Vol. 26 Issue 6, p550 

    Background Drug-eluting stents (DES) are currently the most popular treatment modality for restenosis in bare metal stents and DES. This study compares risks of adverse cardiovascular events between DES-treated in-stent restenosis (ISR) and de novo lesions, an area that has not been...

  • Incidence of Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome and Impact on Patient Outcome. Bonnet, Maryline; Baudin, Elisabeth; Jani, Ilesh V.; Nunes, Elizabete; Verhoustraten, François; Calmy, Alexandra; Bastos, Rui; Bhatt, Nilesh B.; Michon, Christophe // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Objectives and Design:We used data from a randomized trial of HIV-tuberculosis co-infected patients in Mozambique to determine the incidence and predictors of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (IRIS) occurring within 12 weeks of starting...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics